|
|
(HealthNewsDigest.com) – ATLANTA–Researchers at Winship Cancer Institute have developed a technique for detecting an “oncometabolite,” a chemical produced by some brain tumors’ warped metabolism, via non-invasive imaging.
Their approach could allow doctors to know not only that a brain tumor is there, but also that it carries a particular genetic mutation.
The researchers’ technique uses magnetic resonance spectroscopy (MRS) to measure a chemical, 2-hydroxyglutarate, that is scarce in normal tissues. 2-hydroxyglutarate is produced by some types of brain tumors carrying mutations in an enzyme called isocitrate dehydrogenase (IDH).
The results were published this week by the Journal of Molecular Medicine.
Full release:
http://bit.ly/braintumorimagingmutations
Interact with Emory Health Sciences:
http://bit.ly/emoryhealthscisocial
# # #
For advertising and promotion on HealthNewsDigest.com please contact Mike McCurdy: [email protected] or 877-634-9180
HealthNewsDigest.com is syndicated worldwide, and our content is free to all media. www.HealthNewsDigest.com